Gerber Kawasaki Wealth & Investment Management’s Fulgent Genetics FLGT Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,706	Closed	-$529K	–	246
2022 Q2	$529K	Sell	9,706 -24,141	-71%	-$1.33M	0.05%	154
2022 Q1	$2.13M	Sell	33,847 -25,900	-43%	-$1.71M	0.17%	78
2021 Q4	$5.91M	Sell	59,747 -19,360	-24%	-$1.7M	0.47%	43
2021 Q3	$7.07M	Buy	79,107 +38,504	+95%	+$3.5M	0.91%	26
2021 Q2	$3.74M	Sell	40,603 -5,382	-12%	-$430K	0.38%	51
2021 Q1	$4.44M	Sell	45,985 -4,691	-9%	-$484K	0.53%	41
2020 Q4	$2.64M	Buy	+50,676	New	+$2.12M	0.37%	51

Other funds holding FLGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's FLGT Position: Q3 2022 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 9,706 shares — an estimated $529K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in FLGT in Q4 2020 and held it in 7 quarters. The position peaked at $7.07M in Q3 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

Gerber Kawasaki Wealth & Investment Management reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
Gerber Kawasaki Wealth & Investment Management sold 9,706 Fulgent Genetics shares in Q3 2022, an estimated $529K.
Gerber Kawasaki Wealth & Investment Management first reported a position in Fulgent Genetics in Q4 2020 and held it in 7 quarters.
Gerber Kawasaki Wealth & Investment Management's Fulgent Genetics position peaked at $7.07M in Q3 2021.
235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q3 2022, filed 15 Nov 2022.